In the News
White Manna Capital helps bring innovative solutions in the life sciences to life. Explore a collection of press and media featuring our work and people.
Articles & Publications
FDA Moves To Block Some Compounded GLP-1s - Here's What It Means For Online Prescriptions
Forbes Health featured White Manna Capital Partners Founder William Soliman on the FDA's proposal to remove several compounded GLP-1 medications from the 503B bulks list and what that could mean for online prescriptions.
Video
ABC News on AI in Drug Discovery
White Manna Capital Partners Founder/CIO, William Soliman, PhD, featured on ABC News discusses the Eli Lilly- Insilico Medicine $2.75B deal on AI in Drug Discovery.
Video
Middle East Drug Supply Chain Outlook
White Manna Capital Partners Founder/CIO, William Soliman, PhD, discusses the geopolitical conflicts in the Middle East and how the war could impact the drug supply chain.
Video
Vaccines, Autism, and Public Health
White Manna Capital Partners Founder/CIO, William Soliman, PhD, discusses vaccines, autism and more with President/CEO of Immunize.org Dr. Kelly Moore.
Articles & Publications
Oligonucleotide Therapeutics At Scale: Bottlenecks, Breakthroughs, And What Comes Next
A conversation with William Soliman, Ph.D., BCMAS, founder & CIO, White Manna Capital
Podcasts
The Future of Healthcare Innovation
Michael Peres sits down with White Manna Capital Founder, Dr. William Soliman to discuss AI, the life sciences, and biotech's latest innovations shaping the future of healthcare.
Articles & Publications
UK Risks Losing Its Lead in Global Pharmaceutical Innovation
White Manna Capital Founder, Dr. William Soliman discusses the UK global pharmaceutical market and the challenges facing the country's position as a leader in pharmaceutical innovation.